88IV - Public company info - Everest Medicines Limited

Input the stock code or the company name

Everest Medicines Limited, 01952.HK - Cash Flow	2019-12	2018-12
Net Cash Flow from Operating Activities	-88,712	-106,990
Net Cash Flow from Return on Investments & Servicing of Finance	55	23
Interest Received	55	23
Interest Paid	0	0
Dividend Received	0	0
Dividend Paid	0	0
Others	0	0
Taxes (Paid) / Refunded	0	0
Net Cash Flow from Investing Activities	-47,365	-406,325
Additions to Fixed Assets	-7,083	-2,904
Disposal of Fixed Assets	0	0
Increase in Investments	98,442	0
Decrease in Investments	0	-21,714
Net Cash Flow with Related Parties	70,298	463,585
Others	-209,022	-845,292
Net Cash Flow before Financing Activities	-136,022	-513,292
Net Cash Flow from Financing Activities	61,996	461,370
New Loans	0	0
Loans Repayment	-8,302	-5,532
Fixed Income/Debt Instruments	0	0
Repayment of Fixed Income/Debt Instruments	0	0
Equity Financing	0	3,317
Net Cash Flow with Related Parties	70,298	463,585
Others	0	0
Increase(Decrease) in Cash & Cash Equivalents	-74,026	-51,922
Cash & Cash Equivalents at Beginning of Year	183,503	226,120
Net Cash Flow due to Change in Exchange Rate/Others	-3,416	9,305
Cash & Cash Equivalents at End of Year	106,061	183,503
Currency	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Everest Medicines Limited , 01952.HK